WGS
GeneDx Holdings Corp.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$85.99
−1.60%2
Insider buys (3m)
9
Insider sells (3m)
$9.9M
Net value (3m)
+62.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 717 | $0.00 |
| Sep 3, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 372 | $84 |
| Jul 1, 2026 | GARDNER MARK A · officer: President | A-Award | 35,441 | $0.00 |
| Jun 23, 2026 | Meister Keith A. · director, 10 percent owner: | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | Leproust Emily M. · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | Casdin Eli · director, 10 percent owner: | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Meister Keith A. · director, 10 percent owner: | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Casdin Eli · director, 10 percent owner: | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | RUCH JOSHUA · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | RUCH JOSHUA · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Leproust Emily M. · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | PFENNIGER RICHARD C JR · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | Fuchs Thomas · director | A-Award | 4,248 | $0.00 |
| Jun 23, 2026 | Ryan Jason · director | M-Exempt | 3,576 | $0.00 |
| Jun 23, 2026 | PFENNIGER RICHARD C JR · director | A-Award | 4,248 | $0.00 |
| Jun 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 760 | $60 |
| Jun 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 7,197 | $0.00 |
| Jun 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 2,429 | $62 |
| Jun 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 18,750 | $0.00 |
| Jun 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 5,932 | $61 |
| Jun 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 2,106 | $61 |
| Jun 18, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 863 | $62 |
| Jun 18, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 2,140 | $60 |
| Jun 11, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | Sale | 1,266 | $54 |
| Jun 11, 2026 | Feeley Kevin · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 2,462 | $0.00 |
| Jun 11, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | Sale | 3,639 | $54 |
| Jun 11, 2026 | Stueland Katherine · director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 6,546 | $0.00 |
| Jun 8, 2026 | Casdin Capital, LLC · director, 10 percent owner: | Purchase | 150,000 | $56 |
| Jun 8, 2026 | Casdin Capital, LLC · director, 10 percent owner: | Purchase | 50,000 | $53 |
| May 20, 2026 | Casdin Capital, LLC · director, 10 percent owner: | Purchase | 185,000 | $43 |
Institutional positioning
13F filings over the trailing two quarters
New 97Increased 189Reduced 136Sold out 74
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Corvex Management LP | Increased | 4,784,570 | Aug 14, 2026 |
| Casdin Capital, LLC | Increased | 3,707,164 | Aug 14, 2026 |
| CORVEX MANAGEMENT LP | Increased | 3,228,149 | May 15, 2026 |
| CASDIN CAPITAL, LLC | Unchanged | 3,007,164 | May 15, 2026 |
| BlackRock, Inc. | Increased | 1,706,239 | Aug 7, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,669,441 | Aug 14, 2026 |
| ARK Investment Management LLC | Increased | 1,610,189 | Aug 14, 2026 |
| BLACKROCK, INC. | Reduced | 1,550,708 | May 13, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | Increased | 1,400,653 | Aug 12, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | Increased | 1,369,108 | May 11, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1,334,980 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Increased | 1,324,583 | May 12, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,220,502 | Mar 25, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,045,962 | Sep 2, 2026 |
| MORGAN STANLEY | Increased | 988,297 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026